SEC Form 4 · accession 0001209191-17-007450
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey N West
Officer — SVP & Controller
Period of report
Feb 1, 2017
Accepted (ET)
Feb 3, 2017 · 12:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Feb 1, 2017 | X | 1,528 | $40.63 | A | 12,903 | D | |
| Ordinary Common Stock, $0.01 par value | Feb 1, 2017 | X | 1,818 | $41.25 | A | 14,721 | D | |
| Ordinary Common Stock, $0.01 par valueF2 | Feb 1, 2017 | S | 3,346 | $76.0463 | D | 11,375 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy(F4,F3 | $40.63 | Feb 1, 2017 | X | 1,528 | D | — | Mar 2, 2017 | Common Stock | 1,528 | 6,873 | D |
| Stock Option (right to buy)F4,F3 | $41.25 | Feb 1, 2017 | X | 1,818 | D | — | Aug 1, 2017 | Common Stock | 1,818 | 8,182 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $76.00 to $76.20, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F3All of the stock options in this tranche have vested in full.
- F4Not applicable.